March 16, 2010BanksKey stock ideas – EuropeWe are concerned that many retail banks in Europe will beheld back by weak loan growth, lower-<strong>for</strong>-even-longer interestrates, funding costs <strong>and</strong> provisions stabilizing but not gappingdown quickly. We there<strong>for</strong>e have a bias to some capitalmarket banks among our preferred names.Exhibit 39BARC, BAC, JPM <strong>and</strong> CSG look the best value on 2year <strong>for</strong>ward ROE vs price to bookPrice/ 09 Tangible Equity2.5 x2.0 x1.5 x1.0 x0.5 xCBNPPEuropean AverageDBKBARCSocGenUBSJPMUS Average0.0 x10% 12% 14% 16% 18% 20% 22% 24% 26% 28%2012e Return on Tangible EquitySource: Morgan Stanley Research estimatesBARC – Overweight, PT 440p. We think the marketunderestimates Barclays’ operating leverage once marksfall away. We calculate a Barclays Capital divisional 2011PBT of £7.0bn is achievable on a lower-than-guided costto net income ratio. Assuming non-recurrence of creditmarks, normalization of impairments <strong>and</strong> >25% compcost/head growth in 2011 vs 2009, we think BarCap canachieve a cost to net income ratio of 56% in 2011 (vsguidance 65-75%), delivering 72% of <strong>for</strong>ecast group PBTof £9.7bn in 2011.CSG – Overweight, PT SFr71. We see a constructiveoutlook <strong>for</strong> the investment bank, where CSG appears to beholding <strong>and</strong> even winning share, even if in a shrinking topline. YTD CSG is #5 in ECM <strong>and</strong> #3 in DCM YTD.Although we think equity trading has been sluggish, weraise our EPS by 4-5%, largely due to FX. We also believethat CSG is likely to overtake UBS as the world’s largestprivate bank in the next 12 months <strong>and</strong> that inflows remainvery strong, even if margins will dip from the new businessstrain. We see good value in the shares, which are tradingon 7x 2011e EPS <strong>and</strong> 2.5x TNAV (implying the market<strong>for</strong>ecasts a 24% ROTE vs our 27% <strong>for</strong>ecast <strong>for</strong> 2012).UBS – Equal-weight, PT SFr16.6. With the Europeanlarge cap investment banks, UBS is our least preferredBACCSGname, although in the wider context of pan-Europeanbanks, given our cautious view on trends on provisions,macro <strong>and</strong> regulation, there are other banks where we aremore bearish.We appreciate the turnaround potential in UBS led by astrong new management team, but we continue to thinkthat several headwinds will slow the bank’s turnaround,<strong>and</strong> we there<strong>for</strong>e see better value in other names. First,we think UBS continues to see outflows in 2009 <strong>and</strong><strong>for</strong>ecast ~SFr40bn of outflows (probably the highest sellsideestimate) <strong>and</strong> don’t expect inflows until 2010. We alsothink margins will remain subdued as the ‘dash the cash’<strong>and</strong> retention hurt gross margins. In the investment bank,we think the reasonable but challenging industry top linewill make major advances in revenues much morechallenging, despite material improvement year on year.February has been tough <strong>for</strong> most banks <strong>and</strong> investors,<strong>and</strong> we think the high expectations will take time toachieve, although we think they may have made someprogress in FICC. We also note monoline exposure,which, although well marked, could cause further materiallosses should any monolines restructure. SFr18bn instudent loans leaves another risk concentration.Despite the longer-term potential we see <strong>for</strong> turnaround, at~11.3x 10e <strong>and</strong> ~9.6x 11e we see less upside than <strong>for</strong>other European capital market banks we cover. For UBS<strong>and</strong> CSG we are increasing our 2010 estimates dueprimarily to FX. We raise our 2010 EPS <strong>for</strong> UBS by 11%<strong>and</strong> <strong>for</strong> CSG by 4%, reflecting the significant move in thedollar <strong>and</strong> markets since we last wrote. Moreover, we seelimited upside to our price target of SFr 16.6 <strong>and</strong> see littlecarry to hold without clear upside to the restructuring case.We also <strong>for</strong>ecast no dividend until 2012. At 2.2x TNAV, thestock is implying 21% RoTE vs our 20% <strong>for</strong>ecast <strong>for</strong> 2012,suggesting the stock is up with events. This said, we notethat, given such a high cost/income ratio in the investmentbank, the operational gearing of the investment bankmakes UBS in part a market call, rather than one wherewe see a lot of alpha.Soc Gen – Overweight, PT €63. In a report publishedalongside this note today (Roadmap to crystallize value),we explore potential to unlock value in the group throughrefocusing on the core franchises in Foreign Retail <strong>and</strong>beefing-up underlying ROE in CIB from 20% to 25%through specialization rather than a global player strategy.Based on the strategic analysis we run, we believe thiscould lead to an upgrade of group RoTE from 17.4% to19%, implying a base case value ~€76 vs. €63 today. SGtrades on 1.1x last TNAV, which compares to our 17.4%36
March 16, 2010Banksestimated normalized return on tangible equity. Wecalculate this implies the market is pricing in 2.5x higherlosses on legacy assets than we estimate <strong>and</strong> 1.5x higherlosses than the most bearish estimates on the Street,which looks overdone to us.BNP – Overweight, PT €65. We continue to see upsidefrom the Fortis integration, decent market activity, stableretail <strong>and</strong> cost control. The stock trades at 1.4x last TNAV.We raise our estimates by an average 3%.BME – Underweight, PT €19.1. We still see material risksto earnings from proposed changes to the Spanish marketstructure, based on the losses other exchanges have seento MTFs. The stock trades on 10.5x 2010e, <strong>and</strong> our pricetarget implies ~5% downside potential from current levels.SDR – Overweight, PT £15.65. Schroders is our preferredasset manager, as we think sales momentum isbroadening from corporate bond focus to equities,commodities, alternatives <strong>and</strong> multi-asset. At 10x 2011e(adjusted <strong>for</strong> surplus cash) versus the sector on ~11.5x,we think valuation is undem<strong>and</strong>ing given growth.CBK – Underweight, PT €4.43. We remain UnderweightCBK, as we think the company is still challenged in severalasset quality areas, exposed to sovereign risks in Europethrough ~€133bn public finance exposure (€28bn of whichis in Southern Europe) <strong>and</strong> with a thin capital base. Wewould want to see the common equity component ofCBK’s capital addressed be<strong>for</strong>e we turn more positive, <strong>and</strong>currently calculate a €15bn shortfall of core T1 capital (>2xmarket cap).DX – Underweight, PT €4. Dexia’s 4Q results confirmedour cautious view on the stock. With credit markets underpressure, we expect Dexia to suffer from the doubleimpact of higher cost of funding <strong>and</strong> higher cost ofdeleveraging, which will likely impair group earningsgeneration <strong>and</strong> erode excess capital. Deleveraging is likelyto be more challenging on the back of negative creditmigration, which will not ease further asset disposals.Although we believe much of this is priced in, we remainUnderweight on the stock due to: (1) low visibility ontiming/level of normalized earnings; (2) uncertainty overexcess capital in 2012; (3) the impact from wideningsovereign spreads <strong>and</strong> (4) the lack of upside to our pricetarget, which makes the stock a relative Underweightwithin the sector.Key stock ideas – North AmericaBAC – Overweight, PT $28. BAC is our top pick amongUS large cap banks. It has a skew to early cycle capitalmarkets revenues (25% of revenues) <strong>and</strong> card (18% ofmanaged loan balances). We expect provisions <strong>and</strong> NPLsto start declining in 2010. BAC should begin to regain lostcapital markets share as TARP has been paid back,management has stabilized <strong>and</strong> the US economyrebounds, driving corporate America to increaseinvestment, strategic <strong>and</strong> financing activities. We think BACis attractively priced at 0.7x book, 1.5x tangible <strong>and</strong> 5x2012e normalized EPS, versus peers on an average 1.0xbook <strong>and</strong> 7x 2012 normalized EPS.JPM – Overweight, PT $59. We expect JPM will be oneof the first banks with materially declining NPLs, given itsskew to early cycle card <strong>and</strong> below-average CRE. In<strong>Investment</strong> <strong>Banking</strong>, we expect JPM will continue to takeincremental share beyond its already #1 position in IBfees, given recently increased IT investment, Asia focus<strong>and</strong> talent management. We expect that electronic tradingplat<strong>for</strong>ms, equities <strong>and</strong> commodities will drive $1 billioneach in incremental revenue over time. The fixed incomeinvestment is more about cost saves at this point. Weexpect more investment in Asia, where JPM would like todouble its share. JPM is priced equal to the group at 1.1xbook, 1.6x tangible <strong>and</strong> 7x normalized 2012e EPS. Fasterexit from the credit cycle with lower NPLs, lower provisions<strong>and</strong> faster dividend hikes drive our Overweight view.TD – Overweight, PT C$85. TD is our top pick inCanadian banks, with the most leverage to the USrecovery (25% of loan book). TD targets a 75% retail /25% capital markets business mix. Trading <strong>and</strong>underwriting/advisory revenues remain strong. In fiscalQ110, fixed income trading increased 16% sequentially<strong>and</strong> underwriting/advisory was up 6%. Equities tradingcontracted 43% q/q, but only comprises roughly 20% oftrading. TD saw strong new issue origination on the debtside during the quarter. TD is trading at 11.4x 2010eversus Canadian peer group of the sector at 12.8x. Ourprice target implies ~20% upside from current levels.AMTD – Overweight, PT $28. We are Overweight AMTDbecause we believe the Street underappreciates thecompany’s asset gathering ability, <strong>and</strong> thus gives the stocka lower multiple, despite a similar growth profile to comps(management has eliminated past issues). In theDecember quarter, AMTD once again grew net new assets(NNA) at a higher rate than Schwab, the industry leader interms of total assets.BX – Overweight, PT $18. BX is a low capital intensivemodel with very low enterprise risk. Factoring ininvestment gains supports best-in-class pretax incomemargins of ~50%, high returns on equity (~20%) <strong>and</strong>37
- Page 4 and 5: March 16, 2010BanksIn this report:1
- Page 6 and 7: March 16, 2010Banks2009 core revenu
- Page 8 and 9: March 16, 2010BanksExhibit 7Base ca
- Page 10 and 11: March 16, 2010Banks2) Margins - Tig
- Page 13 and 14: March 16, 2010BanksExhibit 13We saw
- Page 15 and 16: March 16, 2010Banks4) Regulatory Ch
- Page 17 and 18: March 16, 2010BanksExhibit 18Regula
- Page 19 and 20: March 16, 2010Banks5) Funding - dri
- Page 21 and 22: March 16, 2010Banks6) Derivatives M
- Page 23 and 24: March 16, 2010Banks7) Sustainable I
- Page 25 and 26: March 16, 2010BanksExhibit 26We hav
- Page 27 and 28: March 16, 2010Banks9) Compensation
- Page 29 and 30: March 16, 2010BanksExhibit 32Compet
- Page 31 and 32: March 16, 2010BanksReturn character
- Page 33 and 34: March 16, 2010BanksPart 2 - Investm
- Page 35: March 16, 2010BanksThe key point we
- Page 40 and 41: March 16, 2010BanksExhibit 43Indust
- Page 42 and 43: March 16, 2010BanksExhibit 45Europe
- Page 44 and 45: March 16, 2010BanksExhibit 50FICC:
- Page 46 and 47: March 16, 2010BanksExhibit 57Our ba
- Page 48 and 49: March 16, 2010BanksExhibit 61FICC r
- Page 50 and 51: March 16, 2010Banks3. Regulatory ou
- Page 52 and 53: March 16, 2010BanksBasel III: Expec
- Page 54 and 55: March 16, 2010Banks4. Derivatives m
- Page 56 and 57: March 16, 2010BanksKey stock callsB
- Page 58 and 59: March 16, 2010BanksExhibit 78Gap ha
- Page 60 and 61: March 16, 2010BanksOur 2010e EPS mo
- Page 62 and 63: March 16, 2010BanksExhibit 86Group
- Page 64 and 65: March 16, 2010Bankscutting measures
- Page 66 and 67: March 16, 2010Banksis possible if r
- Page 68 and 69: March 16, 2010BanksExhibit 971Q pro
- Page 70 and 71: March 16, 2010Banksupside to fundra
- Page 72 and 73: March 16, 2010BanksImperial Bank of
- Page 74 and 75: March 16, 2010Banksis 30% or more d
- Page 76: MORGAN STANLEY RESEARCHThe Americas